-
PRINCETON, NJ - Nov 14, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced that it has been awarded two new dermal virtual bioequivalence grants by the US Food and Drug Administration (FDA)
Nov 14, 2018
-
GUILDFORD, UNITED KINGDOM - Nov 9, 2018 - MR Solutions continues to expand its range of preclinical scanners with the first showing of its elegant bench top CT scanner
Nov 9, 2018
-
PRINCETON, NJ - Nov 8, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access, today announced that its Evidence, Value & Access team will host an educational symposium and present 18 research posters at ISPOR Europe 2018
Nov 8, 2018
-
BETHESDA, MD - Nov 6, 2018 - The International Biomedical Research Alliance, a non-profit organization which provides programming and funding support for the National Institutes of Health (NIH) Oxford-Cambridge Scholars Program, today announced that Tom Heyman is joining the Alliances board of directors
Nov 6, 2018
-
LOS ANGELES, CA, UNITED STATES - Nov 5, 2018 - SHANGHAI, China, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Shanghai Wision AI
Co., Ltd, a leader in developing computer-aided diagnostic algorithms
and systems to improve the accuracy and effectiveness of diagnostic
imaging, today announced results of a study validating a novel
machine-learning algorithm that improves detection of adenomatous
polyps during colonoscopy
Nov 5, 2018
-
WESTBURY, NY - Nov 5, 2018 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has acquired Biological Specialty Corporation (BSC), a supplier of human blood products and components to the life sciences research community for more than 37 years
Nov 5, 2018
-
PRINCETON, NJ - Nov 1, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, today announced that its scientists will lead 15 sessions, and also host a Phoenix User Group Meeting, at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting – PharmSci 360
Nov 1, 2018
-
SAN FRANCISCO, CA - Oct 30, 2018 -
Cofactor Genomics Launches ImmunoPrismTM Immune Profiling Kit, for Use in Clinical Sequencing Laboratories
--Enables in-house, RNA-based, solid tumor profiling with powerful, cloud-based informatics tools to inform critical clinical decisions--
Cofactor Genomics, a clinical RNA sequencing and translational assay developer, announced today the launch of a RNA-based immune profiling kit developed for laboratories wishing to derive the immune composition of tumor samples
Oct 30, 2018
-
WESTBURY, NY, US - Oct 25, 2018 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has appointed Alan Findlater to the newly-created role of chief commercial officer
Oct 25, 2018
-
PRINCETON, NJ - Oct 24, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, today announced that Craig Rayner, PharmD, MBA, senior vice president, integrated drug development with Certara Strategic Consulting, has been awarded the 2018 Distinguished Alumni Award for the Faculty of Pharmacy and Pharmaceutical Sciences at Monash University
Oct 24, 2018
-
CRAIGAVON, NORTHERN IRELAND, UK - Oct 19, 2018 - Almac Diagnostic Services has launched claraT – a unique software-driven solution, classifying biologically relevant gene expression signatures into a comprehensive, easy-to-interpret report
Oct 19, 2018
-
CARLSBAD, MA, UNITED STATES - Oct 17, 2018 - Marking a milestone in bringing its Oncomine Dx Target Test to Europe, Thermo Fisher Scientific today announced that it has CE-IVD marked its next-generation sequencing (NGS)-based solution that screens biomarkers across solid tumors
Oct 17, 2018
-
WESTBURY, NY, US - Oct 16, 2018 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it is introducing a new internal cloud-based Quality Management System (QMS), Master Control
Oct 16, 2018
-
PRINCETON, NJ, US - Oct 15, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, today announced that it has formed a strategic collaboration with Hedera Hashgraph
Oct 15, 2018
-
PRINCETON, NJ, US - Oct 11, 2018 - WIRB-Copernicus Group® (WCG), the worlds leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced that one of its thought leaders will lead a human gene transfer educational course at the American Biological Safety Association (ABSA) 61st Annual Biological Safety Conference
Oct 12, 2018
-
SUFFERN, CA, UNITED STATES - Oct 8, 2018 - SUFFERN, N.Y., Oct. 08, 2018 (GLOBE NEWSWIRE) -- CDx Diagnostics, an innovator in computer-synthesized, three dimensional tissue analysis for the early detection and surveillance of Barretts esophagus, today announced new data for WATS3D, or Wide Area Transepithelial Sampling with 3D Tissue Analysis, demonstrating the clinical significance of crypt dysplasia as an important risk factor for progression to high-grade esophageal dysplasia or esophageal cancer
Oct 11, 2018
-
CRAIGAVON, NORTHERN IRELAND - Oct 11, 2018 - Almac Diagnostic Services, a global stratified medicine company specialising in biomarker driven clinical trials, has made a significant investment in a new Illumina NovaSeq 6000 sequencer which will benefit Biopharma clients biomarker discovery and clinical trial projects
Oct 10, 2018
-
BETHESDA, MD, US - Oct 9, 2018 - The International Biomedical Research Alliance, a non-profit organization which provides programming and funding support for the National Institutes of Health (NIH) Oxford-Cambridge Scholars Program, today announced that Ralph A
Oct 9, 2018
-
PRINCETON, NJ, US - Oct 9, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, today announced that the US Food and Drug Administration (FDA) has renewed, and in many cases increased, its number of Certara software licenses for reviewing new drug and biologics applications
Oct 9, 2018
-
HEIDELBERG, BOSTON, GERMANY - Oct 9, 2018 -
Hummingbird Diagnostics GmbH today announced that Prof. Dr. med. Jörg Debatin is appointed Chairman of the Supervisory Board with immediate effect
Oct 9, 2018